Applicability of bosentan in Dutch patients with Eisenmenger syndrome: preliminary results on safety and exercise capacity

Por Duffels, M.G.J., Berger, R.M.F., Bresser, P., de Bruin-Bon, H.A.C.M., Hoendermis, E., Bouma, B.J., Mulder, B.J.M.
Publicado em 2006

Decrease in quality of life predicts mortality in adult patients with pulmonary arterial hypertension due to congenital heart disease

Por Blok, I.M., van Riel, A.C.M.J., Schuuring, M.J., Duffels, M.G., Vis, J.C., van Dijk, A.P.J., Hoendermis, E.S., Mulder, B.J.M., Bouma, B.J.
Publicado no Neth Heart J (2015)

Bosentan in pulmonary arterial hypertension: a comparison between congenital heart disease and chronic pulmonary embolism

Por Duffels, M.G.J., van der Plas, M.N., Surie, S., Winter, M.M., Bouma, B., Groenink, M., van Dijk, A.P.J., Hoendermis, E., Berger, R.M.F., Bresser, P., Mulder, B.J.M.
Publicado em 2009